MEDICINES THAT MAKE A DIFFERENCE

Serial Number 85013866
606

Registration Progress

Application Filed
Apr 14, 2010
Under Examination
Jan 25, 2011
Approved for Publication
Nov 10, 2010
Published for Opposition
Nov 30, 2010
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MEDICINES THAT MAKE A DIFFERENCE
Previous Owner: Theravance, Inc.
Classes: 005

Trademark Image

MEDICINES THAT MAKE A DIFFERENCE

Basic Information

Serial Number
85013866
Filing Date
April 14, 2010
Published for Opposition
November 30, 2010
Abandonment Date
March 3, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 3, 2014
Classes
005

Rights Holder

Theravance, Inc.

03
Address
901 GATEWAY BLVD
South San Francisco, CA 90480

Ownership History

Theravance, Inc.

Original Applicant
03
South San Francisco, CA

Theravance, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Beth H. Alter

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

40 events
Date Code Type Description Documents
Mar 3, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 3, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 12, 2014 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 12, 2014 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 26, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 25, 2013 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 23, 2013 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 23, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 1, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 31, 2013 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 24, 2013 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 24, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 7, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 6, 2012 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 3, 2012 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 3, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2011 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 27, 2011 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 31, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 27, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 28, 2011 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 23, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Feb 21, 2011 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 21, 2011 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 21, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 25, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 30, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 10, 2010 NPUB O NOTICE OF PUBLICATION Loading...
Oct 25, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 25, 2010 ALIE A ASSIGNED TO LIE Loading...
Oct 12, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 9, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 8, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 8, 2010 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 23, 2010 CNRT F NON-FINAL ACTION MAILED Loading...
Jul 23, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 21, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 19, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system; pharmaceuticals for the treatment of cancer and pain; anti-infectives; bi-functional and multibinding compounds sold as a component of pharmaceutical preparations for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system and for the treatment of cancer and pain and for use as anti-infectives
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005